Daré Bioscience
(NASDAQ) DARE
Daré Bioscience Financials at a Glance
Market Cap
$42.95M
Revenue (TTM)
$1.03M
Net Income (TTM)
$13.40M
EPS (TTM)
$-1.33
P/E Ratio
-2.22
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$3.02
Volume
1,000
Open
$3.29
Price
$3.02
Volume
1,000
Open
$3.29
Previous Close
$3.02
Daily Range
$2.50 - $3.41
52-Week Range
$1.27 - $9.19
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$3.02
Volume
1,000
Open
$3.29
Previous Close
$3.02
Daily Range
$2.50 - $3.41
52-Week Range
$1.27 - $9.19
DARE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Daré Bioscience
Industry
Pharmaceuticals
Sector
Health CareEmployees
24
CEO
Sabrina Martucci Johnson, MBA
Website
www.darebioscience.comHeadquarters
San Diego, CA 92122, US
DARE Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-13%
Net Income Margin
-13%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-41%
Earnings Yield
-45.05%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$42.95M
Shares Outstanding
14.56M
Volume
1.00K
Short Interest
0.00%
Avg. Volume
294.25K
Financials (TTM)
Gross Profit
$1.42M
Operating Income
$13.55M
EBITDA
$11.40M
Operating Cash Flow
$9.89B
Capital Expenditure
$385.28M
Free Cash Flow
$10.27B
Cash & ST Invst.
$24.71B
Total Debt
$2.66B
Daré Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.02M
+1708.4%
Gross Profit
$58.84K
+100.4%
Gross Margin
5.75%
N/A
Market Cap
$42.95M
N/A
Market Cap/Employee
$2.05M
N/A
Employees
21
N/A
Net Income
$1.44M
+73.8%
EBITDA
$802.23K
+85.1%
Quarterly Fundamentals
Net Cash
$22.06B
+153113.6%
Accounts Receivable
$573.06K
+149.2%
Inventory
$0.00
N/A
Long Term Debt
$5.95M
+688.2%
Short Term Debt
$2.10M
+282.2%
Return on Assets
-41.26%
N/A
Return on Invested Capital
-1.54%
N/A
Free Cash Flow
$1.24M
-73.5%
Operating Cash Flow
$1.44M
-72.4%